INTS

Intensity TherapeuticsF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-21

View Chart

RSI (14)

46.1

Neutral

MACD Hist

0.00

Bullish

ATR (14)

0.27

Normal

Vol Z (20)

-0.88

Normal

RET 20D

+10.0%

Positive

Dist 52W High

-86.7%

Below High

Technical chart

1 Year

Candles, moving averages, and volume using the current RankAlpha theme.

As of 2026-07-21

Price

SMA 20

SMA 50

SMA 200

Trend readout

Technical readout

Trend

Mixed trend (SMAs not aligned)

Momentum

Short-term rebound vs weak 3M trend · 20D +10.0% · 60D -16.2%

RSI / MACD

RSI 46.1 (Neutral) · MACD hist +0.00

Volatility

Volatility normal (Z -0.88)

SMA20

4.50

SMA50

4.37

SMA200

7.49

EMA12

4.64

EMA26

4.51

BB Upper

5.21

BB Mid

4.50

BB Lower

3.79

RET 5D

-9.1%

RET 20D

+10.0%

RET 60D

-16.2%

RET 120D

-53.9%

As of 2026-07-21 • Updated nightlySource: Internal modelMethodology